Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
The Journal of Psychology
|
June 26, 2002
The accuracy of abstracts in psychology journals
Alex H S Harris, Sam Standard, Jennifer L Brunning, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 8, 2024
A Skin Testing Strategy for Non-IgE-Mediated Reactions Associated With Vancomycin
Siyan Lyu, Eric T Oliver, Melanie C Dispenza, et al.
Elife
|
April 27, 2021
Asprosin-neutralizing antibodies as a treatment for metabolic syndrome
Ila Mishra, Clemens Duerrschmid, Zhiqiang Ku, et al.
Plos One
|
February 22, 2014
Differential blood and mucosal immune responses against an HIV-1 vaccine administered via inguinal or deltoid injection
Otto O Yang, F Javier Ibarrondo, Charles Price, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 6, 2024
CSF complement proteins are elevated in prodromal to moderate Alzheimer's disease patients and are not altered by the anti-tau antibody semorinemab
Cosme Sandoval, Julie Lee, Balazs Toth, et al.
Gut
|
September 5, 2006
Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis
Christopher G De Vry, Srinivasa Prasad, Laszlo Komuves, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 8, 2024
Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology
Stephen P Schauer, Balazs Toth, Julie Lee, et al.
Plos One
|
July 14, 2012
Laminin-411 is a vascular ligand for MCAM and facilitates TH17 cell entry into the CNS
Ken Flanagan, Kent Fitzgerald, Jeanne Baker, et al.
Research Square
|
June 29, 2026
Asprosin-PTPRD endocrine resistance links brain dysfunction and systemic wasting in Alzheimer's disease
Atul Chopra, Bijoya Basu, Hesong Liu, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 11, 2007
(1R,2S)-4-(2-cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production
Lain-Yen Hu, Daniel Du, Jennifer Hoffman, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
The Journal of Psychology
|
June 26, 2002
The accuracy of abstracts in psychology journals
Alex H S Harris, Sam Standard, Jennifer L Brunning, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 8, 2024
A Skin Testing Strategy for Non-IgE-Mediated Reactions Associated With Vancomycin
Siyan Lyu, Eric T Oliver, Melanie C Dispenza, et al.
Elife
|
April 27, 2021
Asprosin-neutralizing antibodies as a treatment for metabolic syndrome
Ila Mishra, Clemens Duerrschmid, Zhiqiang Ku, et al.
Plos One
|
February 22, 2014
Differential blood and mucosal immune responses against an HIV-1 vaccine administered via inguinal or deltoid injection
Otto O Yang, F Javier Ibarrondo, Charles Price, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 6, 2024
CSF complement proteins are elevated in prodromal to moderate Alzheimer's disease patients and are not altered by the anti-tau antibody semorinemab
Cosme Sandoval, Julie Lee, Balazs Toth, et al.
Gut
|
September 5, 2006
Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis
Christopher G De Vry, Srinivasa Prasad, Laszlo Komuves, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 8, 2024
Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology
Stephen P Schauer, Balazs Toth, Julie Lee, et al.
Plos One
|
July 14, 2012
Laminin-411 is a vascular ligand for MCAM and facilitates TH17 cell entry into the CNS
Ken Flanagan, Kent Fitzgerald, Jeanne Baker, et al.
Research Square
|
June 29, 2026
Asprosin-PTPRD endocrine resistance links brain dysfunction and systemic wasting in Alzheimer's disease
Atul Chopra, Bijoya Basu, Hesong Liu, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 11, 2007
(1R,2S)-4-(2-cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production
Lain-Yen Hu, Daniel Du, Jennifer Hoffman, et al.
Page
of 3